Skip to main content

New design shows body's fluids could power pacemakers without batteries

Charged particles in the human body could someday power pacemakers, according to a team of researchers from UCLA and the University of Connecticut. Powered by this biocompatible super-capacitor, lifesaving medical implants could last last longer with fewer needs for invasive surgery.

There are a few main advantages to this new “biosupercapacitor,” according to its developers — it’s non-toxic, long-lasting, and has the potential to reduce the size of pacemakers by half.

Recommended Videos

“Unlike batteries that use chemical reactions that involve toxic chemicals and electrolytes to store energy, this new class of biosupercapacitors stores energy by utilizing readily available ions, or charged molecules, from the blood serum,” Islam Mosa, first author of the study, said in a statement.

Please enable Javascript to view this content

Traditionally, pacemakers and similar implantable devices get power from batteries that need to be replaced through surgical operations once they run out of juice. This new device instead gets energy through electrolytes that readily flow through the body — for example, in blood and urine — while functioning alongside an energy harvester, which converts the body’s heat and movement into electricity.

“Combining energy harvesters with supercapacitors can provide endless power for lifelong implantable devices that may never need to be replaced,” said co-author Maher El-Kady.

Batteries take up about half of a pacemaker’s size. The new device, which is made up of graphene and human proteins, would be smaller than the width of a human hair.

There’s still work to be done though. Supercapacitors have yet to be regularly adopted in medical devices and, since the study simply shows the design is feasible, the researchers will still need to fabricate and test the device.

“In order to be effective, battery-free pacemakers must have supercapacitors that can capture, store, and transport energy, and commercial supercapacitors are too slow to make it work,” said El-Kady.

The design was detailed in a paper published last week in the journal Advanced Energy Materials.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Faraday Future could unveil lowest-priced EV yet at CES 2025
Faraday Future FF 91

Given existing tariffs and what’s in store from the Trump administration, you’d be forgiven for thinking the global race toward lower electric vehicle (EV) prices will not reach U.S. shores in 2025.

After all, Chinese manufacturers, who sell the least expensive EVs globally, have shelved plans to enter the U.S. market after 100% tariffs were imposed on China-made EVs in September.

Read more
What to expect at CES 2025: drone-launching vans, mondo TVs, AI everywhere
CES 2018 Show Floor

With 2024 behind us, all eyes in tech turn to Las Vegas, where tech monoliths and scrappy startups alike are suiting up to give us a glimpse of the future. What tech trends will set the world afire in 2025? While we won’t know all the details until we hit the carpets of the Las Vegas Convention Center, our team of reporters and editors have had an ear to the ground for months. And we have a pretty good idea what’s headed your way.

Here’s a sneak peek at all the gizmos, vehicles, technologies, and spectacles we expect to light up Las Vegas next week.
Computing

Read more
These unique smart glasses skirt hype and solve a real medical problem
Front view of the SolidddVision smartglasses.

Smart glasses are increasingly being pushed as the future of personal computing. But so far, an overwhelming majority have focused on aspects like social media sharing, pulling up AI agents, or media consumption. Soliddd wants to push smart glasses into a challenging niche of medical science.

At CES 2025, the New York City-based company introduced SolidddVision smart glasses. Soliddd claims these are “the first true vision correction for people living with vision loss due to macular degeneration.” Notably, these glasses won’t require any FDA clearance and will enter the market later this year.

Read more